Vol. 64 No. 3 (2018), ORIGINAL ARTICLES. A. PROTOCOLS OF CLINICAL RESEARCH

Vol. 64 No. 3 (2018)

ANALYSIS OF UNFAVORABLE PROGNOSTIC FACTORS IN PATIENTS WHO RECEIVED HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL HEMOPOIETIC STEM CELLS TRANSPLANTATION FOR RELAPSES AND RESISTANT FORMS OF HODGKIN''S LYMPHOMA

ORIGINAL ARTICLES. A. PROTOCOLS OF CLINICAL RESEARCH

https://doi.org/10.37469/0507-3758-2018-64-3-414-418

Published 01.03.2018

Sergey Alekseev⁺⁻
A. Subora⁺⁻
P. Shilo⁺⁻
I. Ishmatova⁺⁻
Tatyana Semiglazova⁺⁻
Larisa Filatova⁺⁻
Svetlana Kuleva⁺⁻
Yuliya Oleynik⁺⁻
Yuliya Chudinovskikh⁺⁻
Yevgeniya Kharchenko⁺⁻
Margarita Motalkina⁺⁻
Ilya Zyuzgin⁺⁻
S. Shalaev⁺⁻

Sergey Alekseev

N.N. Petrov National Medical Research Center of Oncology

A. Subora

N.N. Petrov National Medical Research Center of Oncology

P. Shilo

N.N. Petrov National Medical Research Center of Oncology

I. Ishmatova

N.N. Petrov National Medical Research Center of Oncology

Tatyana Semiglazova

N.N. Petrov National Medical Research Center of Oncology, I.I. Mechnikov North-West State Medical University

Larisa Filatova

N.N. Petrov National Medical Research Center of Oncology

Svetlana Kuleva

N.N. Petrov National Medical Research Center of Oncology

Yuliya Oleynik

N.N. Petrov National Medical Research Center of Oncology

Yuliya Chudinovskikh

N.N. Petrov National Medical Research Center of Oncology

Yevgeniya Kharchenko

N.N. Petrov National Medical Research Center of Oncology

Margarita Motalkina

N.N. Petrov National Medical Research Center of Oncology

Ilya Zyuzgin

N.N. Petrov National Medical Research Center of Oncology

S. Shalaev

N.N. Petrov National Medical Research Center of Oncology

##article.numberofdownloads## 20

##article.numberofviews## 137

PDF (Русский)

Keywords

HODGKIN'S LYMPHOMA
HIGH DOSE CHEMOTHERAPY
AUTOLOGOUS STEM CELL TRANSPLANTATION

How to Cite

Alekseev, S., Subora, A., Shilo, P., Ishmatova, I., Semiglazova, T., Filatova, L., Kuleva, S., Oleynik, Y., Chudinovskikh, Y., Kharchenko, Y., Motalkina, M., Zyuzgin, I., & Shalaev, S. (2018). ANALYSIS OF UNFAVORABLE PROGNOSTIC FACTORS IN PATIENTS WHO RECEIVED HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL HEMOPOIETIC STEM CELLS TRANSPLANTATION FOR RELAPSES AND RESISTANT FORMS OF HODGKIN’’S LYMPHOMA. Voprosy Onkologii, 64(3), 414–418. https://doi.org/10.37469/0507-3758-2018-64-3-414-418

Abstract

High dose chemotherapy (HDCT) with autologous stem cell transplantation (ASCT) is suggested as the standard of treatment of patients with relapsed or refractory Hodgkin’s lymphoma (HL) providing long-term disease-free survival in over 50 % of patients. The insufficient number of Russian medical centers, which can provide HDCT with ASCT, result into a broken chain of treatment. The main goal of this thesis is the evaluation of a timely mannered qualified medical help as potential independent prognosis factor. Our study included data of patients with refractory or relapsed HL who underwent treatment between 2013 and 2017 in our Center. Due to our data the negative prognostic factors affecting progression-free survival are: primary refractory disease (60 % vs 94 %; HR 2,1 [95 % CI 1.20-3.56], p=0.041); response for the 1st line of salvage therapy less than complete remission (CR) (35 % vs 91 %; HR 2,4 [95 % CI 1.81-3.24], p=0.022), presence of chain treatment disruption (41 % vs 90 %; HR 2,9 [95 % CI 2.43-4.2], p=0.029), disease status less than CR prior ASCT (29 % vs 87 %; HR 4,3 [95 % CI 2.9-6.1], p=0.009). Our results demonstrate that timely mannered qualified medical care is a key component that improves the survival of patients with relapses and refractory forms of Hodgkin’s lymphoma.

https://doi.org/10.37469/0507-3758-2018-64-3-414-418

##article.numberofdownloads## 20

##article.numberofviews## 137

PDF (Русский)

References

Moccia A.A., Donaldson J., Chhanabhai M. et al. International prognostic score in advancedstage Hodgkin's lymphoma: altered utility in the modern era // J. Clin. Oncol. - 2012. - Vol. 30. - P. 3383-3388.

Meyer R.M., Hoppe R.T. Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy // Hematology Am. Soc. Hematol. Educ. Program. - 2012. - Vol. 2012. - P 313-321.

Kuruvilla J. Standard therapy of advanced Hodgkin lymphoma // Hematology Am. Soc. Hematol. Educ. Program. - 2009. - Vol. 2009. - P. 497-506.

Smith S.D., Moskowitz C.H., Dean R. et al. Autologous stem cell transplant for relapsed/refractory Hodgkin lymphoma: results from two transplant centres // Br. J. Haematol. - 2011. - Vol. 153. - P. 358-363.

Majhail N.S., Weisdorf D.J., Defor TE. et al. Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma // Biol. Blood Marrow Tranwsplant. - 2006. - Vol. 12. - P. 1065-1072.

Sorohi B., Cunningham D., Powles R. et al. Longterm outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma // Ann. Oncol. - 2008. - Vol. 19. - P. 312-319.

Schmitz N., Pfstner B., Sextro M. et al. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantationfor relapsed chemosensitive Hodgkin's disease: a randomized trial // Lancet. - 2002. - Vol. 359. - P. 2065-2071.

Rancea M., Monsef I., von Tresckov B. et al. Highdose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma // Cochrane Database Syst. Rev. - 2013. - Vol. 6. - CD009411.

Cheson B.D., Horning S.J., Coiffier B. et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group // J. Clin. Oncol. - 1999. - Vol. 17(4). - P. 1244.

Josting A., Raemakers J.M., Diehl V. et al. New concepts for relapsed Hodgkin>s disease // Ann. Oncol. - 2002. - Vol. 13. - suppl 1. - P. 117-121.

Pavone V., Gaudio F., Console G. et al. Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation // Bone Marrow Transplant. - 2006. - Vol. 37. - P. 719-724.

Моталкина М.С., Кулева С.А., Алексеев С.М. и др. Современные способы улучшения мобилизации стволовых кроветворных клеток: обзор литературы // Medline.ru. - 2015. - Т 16. - С. 916-933.

Sharma A., Kayal S., Iqbal S. et al. Comparison of BEAM vs LEAM regimen in autologous transplant for lymphoma at AIIMS. - Springerplus, 2013. - Vol. 2. - P. 489.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

Nikita Burlov, Gleb Khrykov , Sergey Alekseev , Evidence-based medicine – achievements и disadvantages , Voprosy onkologii : Vol. 68 No. 5 (2022)
Tatyana Semiglazova, Yevgeniya Tsyrlina, Artem Poltoratskiy, Yekaterina Busko, Vladislav Semiglazov, Anna Artemeva, Sergey Ivanov, Lev Bershteyn, Vladimir Anisimov, Aleksey Belyaev, Vladimir Semiglazov, V. Kostorov, Aleksey Novik, Boris Kasparov, Mikhail Osipov, Petr Krivorotko, Veronika Klimenko, Garik Dashyan, Ruslan Paltuev, Yelena Zhiltsova, Tengiz Tabagua, Aleksandr Komyakhov, Kirill Nikolaev, Viktoriya Bashlyk, Roman Donskikh, V. Apollonova, MELATONIN AND METFORMIN IN NEOADJUVANT HORMONOTHERAPY IN LOCALLY ADVANCED BREAST CANCER , Voprosy onkologii : Vol. 64 No. 5 (2018)
Boris Kasparov, Tatyana Semiglazova, Denis Kovlen, Gennadiy Ponomarenko, Valeriya Klyuge, Anton Krutov, Vladislav Osetnik, M. Tynkasova, Kristina Kondrateva, O. Zaozerskiy, Vladislav Semiglazov, A. Nosov, Aleksey Belyaev, REHABILITATION OF PATIENTS WITH PROSTATE CANCER , Voprosy onkologii : Vol. 66 No. 2 (2020)
Valentina Chulkova, Yelena Pestereva, Elvira Karpova, Nelli Khrustaleva, Tatyana Semiglazova, M. Rogachev, Aleksey Belyaev, EMOTIONAL BURNOUT AND ISSUES OF PROFESSIONAL PSYCHOLOGICAL TRAINING OF ONCOLOGISTS , Voprosy onkologii : Vol. 66 No. 2 (2020)
Mariia Urezkova , Tatyana Semiglazova , Anna Artemyeva , Asel Kudaybergenova , Vladislav Semiglazov , Petr Krivorotko, Vladimir Semiglazov , Results of FISH study of HER2 in triple-positive breast cancer , Voprosy onkologii : Vol. 69 No. 2 (2023)
Svetlana Kuleva, Svetlana Ivanova, Andrey Karitskiy, Darya Zvyagintseva, SINGLE-FACTOR LINEAR REGRESSION MODEL OF HODGKIN’S LYMPHOMA IN ADOLESCENTS , Voprosy onkologii : Vol. 63 No. 2 (2017)
Marina Popova, Andrey Chekalov, Ivan Tsygankov, Yuliya Rogacheva, Marina Demchenkova, Maria Grigoreva, Olga Uspenskaya, Olga Ruzhinskaya, Vsevolod Potapenko, Nadezhda Medvedeva, Ilya Zyuzgin, Kamil Kaplanov, Tatiana Ksenzova, Alexander Levanov, Olga Samoylova, Nikita Volkov, Anastasya Beynarovich, Artem Gusak, Kirill Lepik, Nataliya Mikhailova, Vadim Baykov, Alexander Kulagin, Burkitt lymphoma in patients with HIV infection: results of a Russian multicenter study , Voprosy onkologii : Vol. 68 No. 6 (2022)
Valentina Chulkova, Yelena Pestereva, Taras Popov, Anatoliy Yalov, Tatyana Semiglazova, D. Rysenkova, ATTITUDE OF CANCER PATIENTS TO TREATMENT AT SYSTEMIC THERAPY METHODS , Voprosy onkologii : Vol. 64 No. 3 (2018)
Valentina Chulkova, Tatyana Semiglazova, Margarita Vagaytseva, Andrey Karitskiy, Yevgeniy Demin, Viktoriya Fedorova, Yelena Pestereva, Aleksey Belyaev, K. Kondrateva, PSYCHOLOGICAL REHABILITATION AND SCREENING OF EMOTIONAL STRESS IN CANCER PATIENTS , Voprosy onkologii : Vol. 63 No. 2 (2017)
Yevgeniya Kharchenko, Tatyana Semiglazova, Anna Artemeva, Galina Kireeva, I. Polyatskin, Ilya Zyuzgin, Larisa Filatova, Yuliya Chudinovskikh, Margarita Motalkina, Yuliya Oleynik, PROGNOSTIC IMPACT OF IMMUNOHISTOCHEMICAL AND MOLECULAR GENETIC MARKERS IN DIFFUSE LARGE B-CELL LYMPHOMA , Voprosy onkologii : Vol. 66 No. 1 (2020)

1 2 3 4 > >>